Coltene Holding AGCLHLF 68 ROA % is 11.97% as of Dec. 2025, which is 9% above its 10-year median of 10.95. GuruFocus rates CLHLF with a GF Score™ of 68/100 and a GF Value™ of $66.41. The stock has 3 warning signs investors should review. Among 857 Medical Devices & Instruments companies, Coltene Holding AG ranks better than 81.91% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Coltene Holding AG's annualizedNet Income for the quarter that ended in Dec. 2025 was $26.8 Mil.
Coltene Holding AG's average Total Assets over the quarter that ended in Dec. 2025 was $223.9 Mil. Therefore, Coltene Holding AG's annualized ROA % for the quarter that ended in Dec. 2025 was 11.97%.
The historical rank and industry rank for Coltene Holding AG's ROA % or its related term are showing as below:
CLHLF'
s ROA % Range Over the Past 10 Years
Min: 4.36 Med: 10.95 Max: 16.94
Current: 8.19
During the past 13 years, Coltene Holding AG's highest ROA % was 16.94%. The lowest was 4.36%. And the median was 10.95%.
CLHLF's ROA % is ranked better than 81.91% of 857
companies
in the Medical Devices & Instruments industry
Industry Median: 0.59
vs CLHLF: 8.19
Coltene Holding AG (OTCPK:CLHLF) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Coltene Holding AG ROA % Related Terms
Coltene Holding AG ROA % Historical Data
* Premium members only.
The historical data trend for Coltene Holding AG's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Coltene Holding AG's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Coltene Holding AG ROA % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Coltene Holding AG's ROA % distribution charts can be found below:
* The bar in red indicates where Coltene Holding AG's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
ROA % is displayed in the 30-year financial page.
Coltene Holding AG (CLHLF) has a ROA % of 11.97% as of Dec. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Coltene Holding AG and its competitors. This is near median its historical median of 10.95. Over the past decade, Coltene Holding AG's ROA % has ranged from 4.36 to 16.94. According to the industry distribution chart, Coltene Holding AG ranks #155 out of 857 companies in the Medical Devices & Instruments industry, placing it in the top 18.1%.
Is Coltene Holding AG's ROA % too high?
Coltene Holding AG's current ROA % of 11.97% is near median its 10-year median of 10.95. Over the past 10 years, this metric has ranged from a low of 4.36 to a high of 16.94. The Medical Devices & Instruments industry median ROA % is 0.59. Coltene Holding AG's value of 11.97% is 1928.8% above this industry median. Based on the distribution chart, Coltene Holding AG ranks #155 out of 857 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Coltene Holding AG has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Coltene Holding AG's ROA % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Coltene Holding AG ranks #155 out of 857 companies for ROA %. This places Coltene Holding AG in the top 18% of its industry — outperforming the majority of peers. The industry median ROA % is 0.59. Coltene Holding AG's value of 11.97% is 1928.8% above this benchmark. Historically, Coltene Holding AG's own ROA % has ranged from 4.36 to 16.94 over the past decade. While the company's 10-year median is 10.95 vs. the industry median of 0.59, Coltene Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.59, based on 857 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Coltene Holding AG's current ROA % of 11.97% is 1928.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Coltene Holding AG and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Coltene Holding AG's current ROA % is 11.97%, which is near median its own 10-year median of 10.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coltene Holding AG stock overvalued right now?
Coltene Holding AG (CLHLF) has a current ROA % of 11.97%. The stock's GF Value™ is $66.41, compared to a current price of $61.16 — trading 7.9% below its estimated fair value. The current ROA % is 11.97%, which is near median its 10-year median of 10.95 and 1928.8% above the Medical Devices & Instruments industry median of 0.59. Coltene Holding AG's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Coltene Holding AG (CLHLF), the current ROA % is 11.97% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Coltene Holding AG (CLHLF) Overvalued in 2026?
Based on GuruFocus' analysis, Coltene Holding AG stock appears to be undervalued.
The current stock price of $61.16 is trading 7.9% below its estimated GF Value™ of $66.41.
Key valuation signals for CLHLF:
ROA %: 11.97% (near median its 10-year median of 10.95)
GF Value™: $66.41 vs. price of $61.16 (7.9% below fair value)
Industry Position: 1928.8% above the Medical Devices & Instruments median (#155 of 857)
No single metric tells the full story. See the CLHLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Coltene Holding AG is a manufacturer and distributor of consumables and small devices for dental practices, dental service organisations (DSOs), dental clinics and laboratories, as well as for non-dental niches (e.g., clinics for ophthalmology or podiatry). The Group develops, manufactures, and sells mainly via distribution channels a broad and comprehensive range of disposables, tools, and equipment for dentists and dental laboratories. Geographically, it operates in EMEA, North America, Latin America, and Asia/Oceania, with maximum from North America.
68GF Score
Get the complete analysis for CLHLF
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLHLF has been successfully added to your 
